cgp 42112a has been researched along with ave 0991 in 2 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (ave 0991) | Trials (ave 0991) | Recent Studies (post-2010) (ave 0991) |
---|---|---|---|---|---|
233 | 0 | 35 | 48 | 0 | 33 |
Protein | Taxonomy | cgp 42112a (IC50) | ave 0991 (IC50) |
---|---|---|---|
Proto-oncogene Mas | Homo sapiens (human) | 0.021 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Juillerat-Jeanneret, L | 1 |
Alenina, N; Bader, M; Lemos, VS; Santos, RA; Silva, DM; Walther, T | 1 |
1 review(s) available for cgp 42112a and ave 0991
Article | Year |
---|---|
The Other Angiotensin II Receptor: AT
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Drug Delivery Systems; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2020 |
1 other study(ies) available for cgp 42112a and ave 0991
Article | Year |
---|---|
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2005 |